Amplify ETF Trust THNR AMEX · Financials · United States
$26.14 +0.44% +$0.12
Summary
Amplify ETF Trust is an ETF - a fund traded on an exchange like a stock - run by Amplify. Positions inside: 22. The ten largest make up 65% of the fund.
- Yearly costs
- 0.59%
- Fund size
- $5.15M
- Positions
- 22
- Dividend yield
- 1.58%
- Running since
- 2024
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 65% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- Costs of 0.59% a year are above the middle of comparable funds (0.45%).
- In the last five years its price once dropped by 33% from its high.
- A young fund: it has been running only since 2024.
- A small fund with $5.15M under management; small funds get closed more often.
- It trades little: only about $36.1K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +8.3%
- 3 months
- -1.6%
- This year
- +3.2%
- 1 year
- +4.5%
- Avg. market cap
- $295.0B
- P/E
- 22.3x
- Forward P/E
- 17.6x
- P/S
- 5.2x
- P/B
- 4.2x
- P/FCF
- 20.9x
- EV/EBITDA
- 14.9x
- Dividend yield
- 1.62%
- ROIC
- 12.6%
- ROE
- 19.8%
- Gross margin
- 79.0%
- Operating margin
- 31.0%
- Net margin
- 18.7%
- Payout ratio
- 36.1%
- Net debt/EBITDA
- 1.6x
- Beta
- 0.40
Weighted average of the 20 largest companies, which make up 99% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 LLEli Lilly LLY 11%
- 2 NVNovo Nordisk NVO 8.7%
- 3 AMAmgen AMGN 6.1%
- 4 AZAstraZeneca AZN 5.9%
- 5 RERegeneron Pharmaceuticals REGN 5.8%
- 6 GIGilead Sciences GILD 5.7%
- 7 RORoche Holding AG ROP.SW 5.7%
- 8 ABAbbVie ABBV 5.7%
- 9 PFPfizer PFE 5.4%
- 10 45Chugai Pharmaceutical Co., Ltd. 4519.T 5.0%
Positions in the fund: 22. The ten largest make up 65% of it.
Composition as of Nov 7, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 57%
- Denmark 12%
- China 11%
- United Kingdom 5.9%
- Other countries 14%
By company size
- Mega cap 46%
- Large cap 37%
- Mid cap 14%
- Small cap 3.2%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (57%). Largest size group: Mega cap (46%).
What does it cost me?
Expensive- A year from $10,000
- $59.00
- Over 20 years
- $2,828
From every $10,000 invested the fund takes $59.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,828.
How has it done?
Growing slowly- Over the last year
- +4.5%
- Deepest drop
- -33%
- Yearly volatility
- 20%
Growth over the last year: 4.5%. Deepest drop in these years: 33% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 1.58%
- Last payment
- $0.41
Over the last 12 months it paid $0.41 per share, which is 1.58% of today's price. The last payment was $0.41 on Dec 30, 2025.
Is it easy to buy and sell?
It trades little- Traded a day
- $36.1K
- Shares a day
- 1.4K
On an average day about $36.1K of the fund changes hands.
How expensive are the companies inside?
Usual valuation- P/E of the companies inside
- 22.3
- Average Bulios Score
- 63 out of 100
Weight by Bulios Fair Price
- Undervalued 42%
- Fairly valued 25%
- Overvalued 33%
On average the companies inside trade for 22.3 times their yearly profit. By Fair Price, 42% of the rated weight comes out as undervalued.
Counted from its largest companies (20), which make up 99% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
OZ OZEM Roundhill Investments - GLP-1 & Weight Loss ETF | United States | 0.59% | $39.7M | -1.1% | Pays out | 68% |
LI LIFE.TO Evolve Global Healthcare Enhanced Yield Fund | Canada | 0.45% | $265.0M | -3.3% | Pays out | 41% |
ME MEDX Horizon Kinetics Medical ETF | United States | 0.85% | $17.7M | +16% | Pays out | 37% |
LM LMAX.TO Hamilton Healthcare YIELD MAXIMIZER ETF | Canada | 0.65% | $180.2M | +3.9% | Pays out | 37% |
PJ PJP Invesco Pharmaceuticals ETF | United States | 0.58% | $367.9M | +28% | Pays out | 37% |
FT FTXH First Trust Nasdaq Pharmaceuticals ETF | United States | 0.60% | $1.18B | +40% | Pays out | 36% |